News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
FDA commissioner defends changes to COVID vaccine recommendations
In a significant shift this week, Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines will no longer be recommended for healthy children and pregnant individuals. That sparked concerns from some public health officials and medical professionals.
11hon MSN
U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...
Hosted on MSN13d
Here's what to know about the FDA's COVID-19 vaccine changesFDA leaders said on May 20 that clinical trials will be ... Vaccine manufacturers have said that because COVID ...
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
Dr. Marty Makary, the Johns Hopkins surgeon and professor who Trump tapped to lead the FDA, clarified the recently changed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback